Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

Value of the Ventilation/Perfusion Scan in Acute Pulmonary Embolism

(1990) · JAMA · doi:10.1001/jama.1990.03440200057023 · Cited by 2,818

Simulation Study of Confounder-Selection Strategies

Maldonado, G., & Greenland, S. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116813 · Cited by 2,491

Selection of Controls in Case-Control Studies

Wacholder, S., McLaughlin, J. K., Silverman, D. T., & Mandel, J. S. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116396 · Cited by 998

Accuracy of clinical assessment of deep-vein thrombosis

Wells, P. S., Hirsh, J., Anderson, D. R., Lensing, A. A., Foster, G., Kearon, C., Weitz, J. I., D'Ovidio, R., Cogo, A., Prandoni, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92535-x · Cited by 786

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

Inman, W. H. W., Vessey, M. P., Westerholm, B., & Engelund, A. (1970) · BMJ · doi:10.1136/bmj.2.5703.203 · Cited by 609

Oral Contraceptives and Cardiovascular Disease

Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051104 · Cited by 494

Investigation of relation between use of oral contraceptives and thromboembolic disease.

Vessey, M. P., & Doll, R. (1968) · BMJ · doi:10.1136/bmj.2.5599.199 · Cited by 471

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91927-9 · Cited by 453

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism

Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417

Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report

Vessey, M. P., & Doll, R. (1969) · BMJ · doi:10.1136/bmj.2.5658.651 · Cited by 403

Statins and the risk of idiopathic venous thromboembolism

Yang, C., Jick, S. S., & Jick, H. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01523.x · Cited by 74

Laboratory Evaluation of Hypercoagulability With Venous or Arterial Thrombosis

Cott, E. M. V., Laposata, M., & Prins, M. H. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1281-leohwv · Cited by 74

Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis

Hennessy, S., Berlin, J. A., Kinman, J. L., Margolis, D. J., Marcus, S. M., & Strom, B. L. (2001) · Contraception · doi:10.1016/s0010-7824(01)00234-7 · Cited by 72

Contraception and Headache

MacGregor, E. A. (2013) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12035 · Cited by 72

Epidemiological assessment of drug-induced disease

Kaufman, D. W., & Shapiro, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02826-9 · Cited by 72

Hormone therapies and venous thromboembolism: where are we now?

Vlieg, A. V. H., & Middeldorp, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04148.x · Cited by 70

Thrombophilia and pregnancy outcomes

Pabinger, I., & Vormittag, R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01417.x · Cited by 70

RETIRED: Contraceptive considerations in obese women

Edelman, A. (2009) · Contraception · doi:10.1016/j.contraception.2009.08.001 · Cited by 69

Low-Dose Hormonal Contraception After Liver Transplantation

Jabiry‐Zieniewicz, Z., Bobrowska, K., Kamiński, P., Wielgoś, M., Zieniewicz, K., & Krawczyk, M. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.02.063 · Cited by 68

Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: A cross-over study

Fleischer, K., Vliet, H. A. V., Rosendaal, F. R., Rosing, J., Tchaikovski, S. N., & Helmerhorst, F. M. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.04.022 · Cited by 68

Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients

Chabbert‐Buffet, N., Amoura, Z., Scarabin, P., Francès, C., Lévy, D., Galicier, L., Wechsler, B., Blétry, O., Pietté, J. C., & Gompel, A. (2010) · Contraception · doi:10.1016/j.contraception.2010.08.012 · Cited by 67

Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow

McColl, M. D., Tait, R. C., Greer, I. A., & Walker, I. D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02633.x · Cited by 67

Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism

Pabinger, I., Grafenhofer, H., Kaider, A., Ilic, A., Eichinger, S., Quehenberger, P., Husslein, P. W., Mannhalter, C., & Lechner, K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.874 · Cited by 66

Choosing the best contraceptive method for the adult with congenital heart disease

Silversides, C. K., Sermer, M., & Siu, S. C. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0043-7 · Cited by 65

Effects on the hemostatic system and liver function in relation to Implanon® and Norplant®

Egberg, N., van Beek, A., Gunnervik, C., Hulkko, S., Hirvonen, E., Larsson‐Cohn, U., & Bennink, H. J. T. C. (1998) · Contraception · doi:10.1016/s0010-7824(98)00070-5 · Cited by 64

Clinical profile of contraceptive progestins

Benagiano, G., Primiero, F. M., & Farris, M. (2004) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180400007736 · Cited by 63

Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States

Schwingl, P. J., Ory, H. W., & Visness, C. M. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70182-1 · Cited by 62

Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

Lidegaard, Ø., & Milsom, I. (1996) · Contraception · doi:10.1016/0010-7824(96)00035-2 · Cited by 62

Preeclampsia up to date—What’s going on?

Bokuda, K., & Ichihara, A. (2023) · Hypertension Research · doi:10.1038/s41440-023-01323-w · Cited by 65

Hemostasis parameters during ovarian stimulation for in vitro fertilization: Results of a prospective study

Biron, C., Galtier, F., Rabesandratana, H., Bernard, I., Aguilar‐Martinez, P., Schved, J., & Hedon, B. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81864-x · Cited by 61

The role of inherited thrombophilia in venous thromboembolism associated with pregnancy

McColl, M. D., Walker, I. D., & Greer, I. A. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08395.x · Cited by 61

Hormone therapy and venous thromboembolism

Peverill, R. E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00079-9 · Cited by 60

Hormonal contraception, thrombosis and age

Lidegaard, Ø. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.950654 · Cited by 57

Contraception for Women in Selected Circumstances

Curtis, K. M., Chrisman, C. E., & Peterson, H. B. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)01984-1 · Cited by 58

Estrogen and progestin components of oral contraceptives: Relationship to vascular disease

Carr, B. R., & Ory, H. W. (1997) · Contraception · doi:10.1016/s0010-7824(97)00029-2 · Cited by 57

Hypercoagulability: Too Many Tests, Too Much Conflicting Data

Bauer, K. A., Rosendaal, F. R., & Heit, J. A. (2002) · Hematology · doi:10.1182/asheducation-2002.1.353 · Cited by 56

Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptives

van Rooijen, M., Silveira, A. M. V., Hamsten, A., & Bremme, K. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00950-5 · Cited by 55

Comparison of estrogenic components used for hormonal contraception

Stanczyk, F. Z., Winer, S. A., Foidart, J., & Archer, D. F. (2023) · Contraception · doi:10.1016/j.contraception.2023.110310 · Cited by 54

Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL

Westhoff, C. L., Jain, J. K., Milsom, I., & Ray, A. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.009 · Cited by 54

Protective Effect of a Thrombin Receptor (Protease-Activated Receptor 1) Gene Polymorphism Toward Venous Thromboembolism

Arnaud, E., Nicaud, V., Poirier, O., Rendu, F., Alhenc‐Gelas, M., Fiessinger, J., Emmerich, J., & Aiach, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.585 · Cited by 54

Risk of venous thrombosis with hormone-replacement therapy

Vandenbroucke, J. P., & Helmerhorst, F. M. (1996) · The Lancet · doi:10.1016/s0140-6736(05)64918-5 · Cited by 54

Cigarette Smoking Women of Reproductive Age Who Use Oral Contraceptives: Results from the 2002 and 2004 Behavioral Risk Factor Surveillance Systems

Regan, A. K., HOGUE, C. J. R., Huber, L. R. B., & Ehrlich, A. C. (2010) · Women s Health Issues · doi:10.1016/j.whi.2010.06.006 · Cited by 52

Combined hormonal contraception and venous thromboembolism

Martínez, F., & Avecilla, À. (2007) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180701300194 · Cited by 51

Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina

Smith, A. M., English, K. M., Malkin, C. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01848 · Cited by 51

Oral contraceptives and venous thromboembolism: Should epidemiologic associations drive clinical decision making?

Westhoff, C. L. (1996) · Contraception · doi:10.1016/0010-7824(96)00111-4 · Cited by 51

Pharmacodynamics of combined estrogen-progestin oral contraceptives: Effects on metabolism

Bastianelli, C., Farris, M., Rosato, E., Brosens, I., & Benagiano, G. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1271708 · Cited by 50

Risk of venous thromboembolic disease in women

Romero, A., Alonso, C., Rincón, M., Medrano, J., Santos‐Lozano, J. M., Calderón, E. J., Marín, I., & González, M.-A. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.11.023 · Cited by 49

The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology

Xu, F., Ma, J., Wang, X., Wang, X., Fang, W., Sun, J., Li, Z., & Liu, J. (2023) · Biomolecules · doi:10.3390/biom13091410 · Cited by 49

9 Haemostatic changes and the oral contraceptive pill

Norris, L., & Bonnar, J. (1997) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(97)80027-2 · Cited by 48

Limited knowledge on progestogen‐only contraception and risk of venous thromboembolism

Bergendal, A., Odlind, V., Persson, I. R., & Kieler, H. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340902730375 · Cited by 48

Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature

Girolami, A., Scandellari, R., Tezza, F., Paternoster, D. M., & Girolami, B. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0009-9 · Cited by 48

Cerebral thrombosis and oral contraceptives

Lidegaard, Ø., & Kreiner, S. (1998) · Contraception · doi:10.1016/s0010-7824(98)00032-8 · Cited by 48

Acquired and Congenital Risk Factors associated with Cerebral Venous Sinus Thrombosis

McBane, R. D., Tafur, A. J., & Wysokiński, W. E. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.04.015 · Cited by 47

Efficacy and Safety of the New Antiandrogenic Oral Contraceptive Belara®

Zahradnik, H. P., Goldberg, J., & Andreas, J. (1998) · Contraception · doi:10.1016/s0010-7824(98)00008-0 · Cited by 47

Effects of oral contraceptives on vascular endothelium in premenopausal women

John, S., Jacobi, J., Schlaich, M. P., Delles, C., & Schmieder, R. E. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.105739 · Cited by 47

Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis

Farris, M., Bastianelli, C., Rosato, E., Brosens, I. A., & Benagiano, G. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1356718 · Cited by 46

Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review

Lete, I., Chabbert‐Buffet, N., Jamin, C., Lello, S., Lobo, P., Nappi, R. E., & Pintiaux, A. (2015) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2015.1050091 · Cited by 47

Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis

Keenan, L., Kerr, T., Duane, M., & Gundy, K. V. (2018) · The Linacre Quarterly · doi:10.1177/0024363918816683 · Cited by 48

Occlusive Vascular Diseases in Oral Contraceptive Users

Godsland, I. F., Winkler, U. H., Lidegaard, Ø., & Crook, D. (2000) · Drugs · doi:10.2165/00003495-200060040-00003 · Cited by 46

Effects of oral contraceptives on hemostasis and thrombosis

Rosing, J., & Tans, G. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70699-x · Cited by 45

Epidemiology of the contraceptive pill and venous thromboembolism

Hannaford, P. C. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70009-3 · Cited by 45

Effects of hormone replacement therapy on blood platelets

Thijs, A., van Baal, W. M., van der Mooren, M. J., Kenemans, P., Dräger, A. M., Huijgens, P. C., & Stehouwer, C. D. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01039.x · Cited by 44

Application of the Caprini Risk Assessment Model in Evaluation of Non–Venous Thromboembolism Complications in Plastic and Reconstructive Surgery Patients

Jeong, H. S., Miller, T. J., Davis, K. E., Matthew, A., Lysikowski, J. R., Lazcano, E., Reed, G., & Kenkel, J. M. (2013) · Aesthetic Surgery Journal · doi:10.1177/1090820x13514077 · Cited by 43

Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives

Hoffmann, H., Moore, C., Zimmermann, H., Elger, W. A. G., Schwarz, S., Gräser, T., & Oettel, M. (1998) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(98)80034-1 · Cited by 43

Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk

Douxfils, J., Morimont, L., & Bouvy, C. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1714140 · Cited by 43

Oral contraceptives and the periodontium

Preshaw, P. M. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2011.00399.x · Cited by 43

Diagnostic Studies for Thrombophilia in Women on Hormonal Therapy and During Pregnancy, and in Children

Brenner, B., Nowak‐Göttl, U., Kosch, A., Manco‐Johnson, M. J., & Laposata, M. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1296-dsftiw · Cited by 43

Use of exogenous estrogens in systemic lupus erythematosus

Mok, C. C., Lau, C. S., & Wong, R. W. S. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.22498 · Cited by 43

Acquired resistance to activated protein C in breast cancer patients

Nijziel, M. R., van Oerle, R., Thomassen, S., Thomassen, S., Pampus, E. C. M. V., Hamulyák, K., Tans, G., & Rosing, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03987.x · Cited by 42

Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology

Gourdy, P., Bachelot, A., Catteau-Jonard, S., Chabbert‐Buffet, N., Christin‐Maître, S., Conard, J., Fredenrich, A., Gompel, A., Lamiche-Lorenzini, F., Moreau, C., et al. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.09.001 · Cited by 40

Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette®): observational studies using the UK General Practice Research Database

Seaman, H. E., de Vries, C. S., & Farmer, R. D. T. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.896 · Cited by 41

Oral Contraceptives: An Update on Health Benefits and Risks

Borgelt, L. M. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31329-8 · Cited by 40

Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study

Martinelli, I., Maino, A., Abbattista, M., Bucciarelli, P., Passamonti, S. M., Artoni, A., Gianniello, F., & Peyvandi, F. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.03.025 · Cited by 42

Evaluation of the American Society of Anesthesiologists Physical Status Classification System in Risk Assessment for Plastic and Reconstructive Surgery Patients

Miller, T. J., Jeong, H. S., Davis, K. E., Matthew, A., Lysikowski, J. R., Cho, M., Reed, G., & Kenkel, J. M. (2014) · Aesthetic Surgery Journal · doi:10.1177/1090820x14525394 · Cited by 39

Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism

Stein, P. D., & Matta, F. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.09.006 · Cited by 39

Drug-Induced Cardiovascular Disorders

Murphy, C. A., & Dargie, H. J. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00005 · Cited by 39

Effects on Hemostasis After Two-Year Use of Low Dose Combined Oral Contraceptives with Gestodene or Levonorgestrel

Prasad, R. N. V., Koh, S. C. L., Viegas, O. A. C., & Ratnam, S. S. (1999) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969900500112 · Cited by 39

Prescribing Oral Contraceptives for Women Older Than 35 Years of Age

Seibert, C. S., Barbouche, E., Fagan, J. M., Myint, E., Wetterneck, T. B., & Wittemyer, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00013 · Cited by 39

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

Soares, G. M., Vieira, C. S., Martins, W. P., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01877.x · Cited by 38

Gender comparisons in pulmonary embolism (results from the International Cooperative Pulmonary Embolism Registry [ICOPER])

Mchugh, K., Visani, L., DeRosa, M., Covezzoli, A., Rossi, E., & Goldhaber, S. Z. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02310-4 · Cited by 36

Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: What advice should we be giving?

Lakasing, L., & Khamashta, M. A. (2001) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118901101195029 · Cited by 36

The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol

Kroll, R., Reape, K. Z., & Margolis, M. B. (2009) · Contraception · doi:10.1016/j.contraception.2009.07.003 · Cited by 35

Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis

Trussell, J., Guthrie, K. A., & Schwarz, E. B. (2008) · Contraception · doi:10.1016/j.contraception.2007.11.012 · Cited by 35

Modern oral contraceptives and cardiovascular disease

Rosenberg, L. A., Palmer, J. R., Sands, M. I., Grimes, D. A., Bergman, U., Daling, J., & Mills, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70168-6 · Cited by 35

Bricolage and Bodies of Knowledge: Exploring Consumer Responses to Controversy about the Third Generation Oral Contraceptive Pill

Hester-Moore, J. S. (2005) · Body & Society · doi:10.1177/1357034x05056192 · Cited by 35

Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women

Sugiura, K., Kobayashi, T., & Ojima, T. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.038 · Cited by 33

Assessment of Coagulation Parameters in Women Affected by Endometriosis: Validation Study and Systematic Review of the Literature

Ottolina, J., Bartiromo, L., Dolci, C., Salmeri, N., Schimberni, M., Villanacci, R., Viganò, P., & Candiani, M. (2020) · Diagnostics · doi:10.3390/diagnostics10080567 · Cited by 35

Comparative Study of the Effects of Combined Oral Contraceptives in Hemostatic Variables

Stocco, B., Fumagalli, H. F., Franceschini, S. A., Martínez, E. Z., Marzocchi-Machado, C. M., de Sá, M. F. S., & Tolói, M. R. T. (2015) · Medicine · doi:10.1097/md.0000000000000385 · Cited by 34

A Benefit-Risk Review of Systemic Haemostatic Agents

Fraser, I. S., Porte, R. J., Kouides, P. A., & Lukes, A. S. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00001 · Cited by 34

Cardiovascular Events Associated With Different Combined Oral Contraceptives

Hannaford, P. C. (2000) · Drug Safety · doi:10.2165/00002018-200022050-00004 · Cited by 34

50 years of “The Pill”: celebrating a golden anniversary

Szarewski, A., Mansour, D., & SHULMAN, L. P. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910793048665 · Cited by 34

Canadian Contraception Consensus

(2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30260-2 · Cited by 33

Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway

Curvers, J., Nap, A. W., Thomassen, S., Nienhuis, S. J., Hamulyák, K., Evers, J. L. H., Tans, G., & Rosing, J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03118.x · Cited by 33

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

Ehrenforth, S., Nemes, L., Mannhalter, C., Rosendaal, F. R., Koder, S., Rintelen, C., Scharrer, I., & Pabinger, I. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00606.x · Cited by 32

Risk of venous thromboembolism with third-generation oral contraceptives: A review

Weiss, G. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70721-0 · Cited by 32

The long term health consequences of polycystic ovary syndrome

Kelly, C. J., Connell, J., Cameron, I. T., Gould, G. W., & Lyall, H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11644.x · Cited by 29

Changes in laboratory markers of thrombotic risk early in the first trimester of pregnancy may be linked to an increase in estradiol and progesterone

Bagot, C. N., Leishman, E., Onyiaodike, C. C., Jordan, F., Gibson, V. B., & Freeman, D. J. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.03.015 · Cited by 30

Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis

Ziller, M., Ziller, V., Haas, G., Rex, J., & Kostev, K. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2983-9 · Cited by 30

The Combined Vaginal Contraceptive Ring, NuvaRing, and Cerebral Venous Sinus Thrombosis: A Case Report and Review of the Literature

Kolacki, C., & Rocco, V. (2011) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2011.06.011 · Cited by 30

Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis

Vlieg, A. V. H., & Rosendaal, F. R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00406.x · Cited by 30

Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism

Grady, D. G., & Sawaya, G. F. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00136-3 · Cited by 30

Towards the genetic basis of cerebral venous thrombosis—the BEAST Consortium: a study protocol

Cotlarciuc, I., Marjot, T., Khan, M. S., Hiltunen, S., Haapaniemi, E., Metso, T. M., Putaala, J., Zuurbier, S. M., Brouwer, M. C., Passamonti, S. M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012351 · Cited by 30

Venous thromboembolism in women taking hormonal contraceptives

Blanco-Molina, Á., & Monréal, M. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.175 · Cited by 32

Fatal Pulmonary Thromboembolism and Hereditary Thrombophilias

Ely, S. F., & Gill, J. R. (2005) · Journal of Forensic Sciences · doi:10.1520/jfs2004315 · Cited by 29

Pharmacoepidemiology

Garbe, E., & Suissa, S. (2005) · Springer eBooks · doi:10.1007/978-3-540-26577-1_31 · Cited by 29

Current reversible contraceptive methods: a global perspective

Huezo, C. M. (1998) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(98)00084-8 · Cited by 29

Risk factors for thromboembolism in teens: when should I test?

Sass, A. E., & Neufeld, E. J. (2002) · Current Opinion in Pediatrics · doi:10.1097/00008480-200208000-00002 · Cited by 28

Managing hirsutism in gynaecological practice

CONN, J. J., & Jacobs, H. S. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10197.x · Cited by 28

Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy

Petri, M. (2001) · Lupus · doi:10.1191/096120301676707393 · Cited by 28

The influence of thrombotic risk factors when oral contraceptives are prescribed a control‐only study

Lidegaard, Ø. (1997) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.1997.tb07855.x · Cited by 28

Two case-control studies: risk of venous thromboembolism with oral contraceptives

Dunn, N. (2011) · BMJ · doi:10.1136/sbmj.d3139

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404

Combined oral contraceptives: venous thrombosis: a Cochrane review

Cheng, L. (2017) · doi:10.3760/cma.j.issn.1671-7368.2017.09.025

Oral contraceptives and venous thromboembolism

Watt, A., Graham, A., Grieve, F., Davie, J., Glasier, A. F., & Persaud, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92446-9 · Cited by 9

Review: Combined oral contraceptives are associated with venous thrombosis

Harper, D. M., Wilfling, L., & Blanner, C. F. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-02012 · Cited by 1